Estefarm Co., Ltd. announced that its three types (FINE, DEEP, Sub-Q) of 'QTFILL PLUS', a filler containing HA (hyaluronic acid), have received product approval from the Australian Therapeutic Goods Administration (TGA) and recently successfully concluded an academic event for local medical professionals.
This event was attended by approximately 100 local medical professionals in Sydney, Australia, and was presented by Director Seungmin Oh of O&Clinic on the topic of “The Mainstream of K-Trends in Filler Injection Techniques Using QTFill.” The lecture focused on introducing facial contouring techniques suitable for K-Trends using QTFILL PLUS, which is made with UHD (Ultra high Density) Cross-linking technology. In the second part of the lecture that followed, a special technique different from existing filler procedures in Australia and Europe was presented for wrinkle improvement procedures and no bleeding procedures, which received a lot of attention from local medical professionals.
The Australian medical aesthetic (injectable) market is estimated to be worth approximately $169.3 million in 2024, and is expected to grow at a CAGR of 13.7% until 2030 (Horizon Grand View Research). Along with botulinum toxin, demand for HA filler procedures is also continuously increasing, making QTFILL PLUS's market entry even more anticipated.
Estefam QTFILL PLUS is composed of various products depending on the viscosity of the product, and its advantage is that it improves viscoelasticity with only a small amount of cross-linking agent. In addition, since receiving CE approval in 2020, it has been expanding its overseas market by obtaining licenses in various countries such as Russia, Vietnam, and Indonesia.
Estefam CEO Oh Se-eok said, “Since the company was founded in 2016, we have been working hard to provide reliable product development and services to customers around the world,” and emphasized, “We will continue to work to increase the company’s reliability along with continuous product development.”
- See more related articles
You must be logged in to post a comment.